RxDoctor Payments Data

Paula Drivas

Physician Assistant · Los Angeles, CANPI 1497819395

Payments from drug & device makers

$380in general payments, 2019–2025

Across 7 payments — averaging $54.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$142
  • Novo Nordisk$120
  • Gilead$35
  • Novartis$30
  • CSL Behring$28
  • Bayer$24

What the payments were for

  • Food & beverage$380100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen2$142
Novo Nordisk1$120
Gilead1$35
Novartis1$30
CSL Behring1$28
Bayer1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$380 in reported general payments places this provider in the 55th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Medicare billing

Part B allowed, 2024
$150,551
Medicare patients
889
Services billed
2,607

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PaxlovidNirmatrelvir/Ritonavir43$1,368
Albuterol Sulfate HfaAlbuterol Sulfate57$1,343
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst43$455
Azithromycin126$450
Diclofenac Sodium17$417
Cephalexin73$351
CefuroximeCefuroxime Axetil34$289
Mupirocin42$206
Cefdinir13$201
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim49$173
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$168
Paxlovid (Eua)Nirmatrelvir/Ritonavir14$144
Naproxen51$131
Doxycycline Hyclate25$130
Triamcinolone Acetonide13$105

Paid to pharmacies, not to this prescriber.

Other physician assistant in Los Angeles

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →